Kerrisdale Capital on the China Medical Short SagaGuest Post
The famous short selling hedge fund, Kerrisdale Capital, is out with its Q3 letter.
Kerrisdale Partners LP achieved a quarterly return, net to investors, of 9.1% for the quarter ended September 30, 2012. The S&P 500 index returned 6.4% during that time.
Since inception, the fund has achieved a return, net to investors, of 742.3%. The S&P 500 index has returned 67.6% during that time.
They detail an extremely interesting story about shorting of a potential fraud . . .
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.